Canopy CEO: We'll 'Disrupt the Heck' Out of Pharma
*By Carlo Versano*
At the end of a week that saw the nascent cannabis sector soar to record valuations (with enough [volatility](https://cheddar.com/videos/making-sense-of-tilrays-stock-chart) to make your head spin), at least one exec isn't getting high off his own supply.
Bruce Linton, CEO of Canopy Growth ($CGC), told Cheddar Friday that he is focused on using a recent $4 billion cash injection from Constellation Brands to accelerate his business operations as new markets open up for legal marijuana use.
The market for legal pot went from a handful of countries like Canada, where Canopy is based, to now over 30 globally, Linton said in an interview, and Constellation's stake "is the kind of rocket fuel we need."
As speculators send the stocks higher ー Canopy is up 100 percent since the August deal, while Tilray ($TLRY) is up 1,000 percent since its July IPO ー Linton is keeping his nose to the grindstone developing new uses for cannabis, illustrated by the 39 patents Canopy filed in the last year just for sleep-related cannabinoid products. He sees other uses as well, from anxiety to sports recovery, which begs the question: is Canopy a pharma company?
"We're going to have enough intellectual property and activity that it would be difficult for pharma companies...not to need to play with us," Linton said. "We're going to disrupt the heck out of them."
Speaking of disruption, Linton said he wasn't bothered by parallels with the dot-com bubble of the early 2000s. He said Canopy had more in common with a Google or Amazon ー established businesses with strong fundamentals ー than any of the internet stocks that were relegated to the tech boneyard after the bubble popped.
But for an industry like cannabis that is entirely dependent on regulation, there will always be a risk, Linton noted. For every country like Canada, which legalized medical marijuana in 2001 and will allow recreational use starting October 17, there's an Italy ー where medical marijuana is legal but heavily restricted ー or a Japan ー where it is strictly outlawed. Put another way, Canopy may have the best legal pot cultivation and distribution in the world, but its long-term success on a global scale may be capped by shifting regulatory and political climates.
Still, Linton sees the writing on the wall in places like South America, Australia, and the EU. As regulatory barriers come down, he said Canopy's strong production operations will lead the market.
"People can fight for who's going to be the second best," Linton said. "We're going to be the best and the largest and the most dominant on the planet over the next decade."
For full interview [click here](https://cheddar.com/videos/canopy-growth-blazing-a-trail).
Anthony Bartolacci, VP of Financial Institutions at Sensor Tower, joined Closing Bell to discuss the factors dragging down Snap and other social media and tech stocks.
David Stryzewski, CEO of Sound Planning Group, joins Cheddar News' Closing Bell, where he says that rate hikes are driving the market right now and outlines what must be in place for a stock rally.
Andrew Arons, Founder and Partner at Synergy Advisory Management Group, joins Cheddar News' Closing Bell, where he breaks down Tuesday's market action and provides his insight on Snap's historic slide after the comments made by CEO Evan Spiegel.
Peter Andersen, CIO at Andersen Capital Management, joins Cheddar News' Closing Bell, where he breaks down Monday's trading action and discusses whether this could be the start of a new rally or a blip in an otherwise disappointing stretch.
The crypto industry is still reeling from Terra's recent crash. The company's blockchain was temporarily halted earlier this month after the collapse of its cryptocurrency Luna (LUNA) and its stablecoin TerraUSD (UST), which led to almost $45 billion being wiped from the tokens' market caps within a week. Now, many are left wondering what Terra's struggles mean for the broader crypto market. Reeve Collins, CEO of the NFT platform BLOCKv, joins Cheddar News' Closing Bell from Davos 2022 to discuss.
China's largest ride-hailing company will no longer be listed on the world's largest stock exchange. Didi shareholders voted on Monday to delist from the New York Stock Exchange, less than a year after launching a $4.4 billion IPO with the most significant U.S. share offering by a Chinese company since Alibaba debuted in 2014. Since going public in June of last year, around $70 billion has been wiped from Didi's market value and shares of the company have dropped nearly 90%. Now, Didi is expected to begin preparations to list in Hong Kong. Kevin T. Carter, founder and Chief Investment Officer of EMQQ Global, joins Cheddar News' Closing Bell to discuss.
Ahead of the Meta shareholder meeting, more than five hundred doctors have jointly sent a letter to investors to hold the Facebook parent accountable for the risks its platforms have posed to the public and mental health. Dr. Rob Davidson, a West Michigan ER physician and executive director of the Committee to Protect Health Care, joined Cheddar News to discuss how medical professionals are coming together to highlight the social media giant's spread of misinformation, especially during the pandemic. "We've seen the direct impacts of misinformation and disinformation that spreads like wildfire on the social media platforms," he said. "Our goal with this letter is to try to get the shareholders of Meta to convince leadership that they need to do a better job."
Snap downgraded its earnings and revenue expectations for the second quarter, saying the "macroeconomic environment" has deteriorated faster than the company anticipated. The warning sent shockwaves through the digital ad industry, dragging down a handful of other tech stocks, including Pinterest, Meta, and Twitter. Daniel Cobb, CEO and Chief Strategy Officer of Daniel Brian Advertising, joined Cheddar to discuss the reason behind this warning, and why it's bringing so many social media stocks down.
